Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of PENG block and lumbar plexus block for fast-track primary hip arthroplasty
2023-507506-14-01Phase 4Authorised
- Sponsor
- Hospital del Mar
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of levobupivacaine (2 arms), sponsored by Hospital del Mar. Primary endpoints: Pain and Quadriceps muscular strength. Planned start Mar 2024; status: authorised.
02
Drugs
levobupivacaine
Beyond the preview
Go deeper on 2023-507506-14-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-507506-14-01.